Human β-defensin 2 may inhibit internalisation of bacillus Calmette-Guérin (BCG) in bladder cancer cells

BJU International

Volumn 112, Issue 6, 2013, Pages 781-790

  Kim, Jung Hoon ^a   Kim, Soon Ja ^a   Lee, Kyung Mee ^a   Chang, In Ho ^a  

^a Chung Ang University College of Medicine   (South Korea)

Author keywords

bacillus Calmette Gu rin; bladder; cancer; human defensin 2

Indexed keywords

BCG VACCINE; BETA DEFENSIN 2; MESSENGER RNA; RECOMBINANT PROTEIN;

ARTICLE; BLADDER CANCER; CANCER CELL; CANCER CELL CULTURE; CELL STIMULATION; CELL VIABILITY; CONFOCAL MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOFLUORESCENCE; INTERNALIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UROTHELIUM;

BACILLUS CALMETTE-GUÉRIN; BLADDER; CANCER; HUMAN Β-DEFENSIN 2;

ADJUVANTS, IMMUNOLOGIC; BCG VACCINE; BETA-DEFENSINS; CELL LINE, TUMOR; CELL SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MYCOBACTERIUM BOVIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; TRANSCRIPTION, GENETIC; URINARY BLADDER NEOPLASMS;

EID: 84884285271     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12196     Document Type: Article

References (25)

1. Malkowicz SB,. Intravesical therapy for superficial bladder cancer. Semin Urol Oncol 2000; 18: 280-288
2. Kresowik TP, Griffith TS,. Bacillus Calmette-Guérin immunotherapy for urothelial carcinoma of the bladder. Immunotherapy 2009; 1: 281-288
3. Chen X, Niyonsaba F, Ushio H, et al. Antimicrobial peptides human beta-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability. Eur J Immunol 2007; 37: 434-444
4. MacRedmond R, Greene C, Taggart CC, McElvaney N, O'Neill S,. Respiratory epithelial cells require Toll-like receptor 4 for induction of human beta-defensin 2 by lipopolysaccharide. Respir Res 2005; 6: 116-126
5. Valore EV, Park CH, Quayle AJ, Wiles KR, McCray PB Jr, Ganz T,. Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. J Clin Invest 1998; 101: 1633-1642
6. Fattorini L, Iona E, Ricci ML, et al. Activity of 16 antimicrobial agents against drug-resistant strains of Mycobacterium tuberculosis. Microb Drug Resist 1999; 5: 265-270
7. Mendez-Samperio P, Miranda E, Trejo A,. Mycobacterium bovis Bacillus Calmette-Guerin (BCG) stimulates human beta-defensin-2 gene transcription in human epithelial cells. Cell Immunol 2006; 239: 61-66
8. de Boer EC, Bevers RF, Kurth KH, Schamhart DH,. Double fluorescent flow cytometric assessment of bacterial internalization and binding by epithelial cells. Cytometry 1996; 25: 381-387
9. Mendez-Samperio P, Alba L, Trejo A,. Mycobacterium bovis-mediated induction of human beta-defensin-2 in epithelial cells is controlled by intracellular calcium and p38MAPK. J Infect 2007; 54: 469-474
10. Ashitani J, Mukae H, Hiratsuka T, Nakazato M, Kumamoto K, Matsukura S,. Plasma and BAL fluid concentrations of antimicrobial peptides in patients with Mycobacterium avium-intracellulare infection. Chest 2001; 119: 1131-1137
11. Ali AS, Lanz M, Townes CL, et al. Release of the anti-microbial peptide beta-defensin 2 protects against attack by flagellated Escherichia coli in human urothelium. European Association of Urology 27th Annual Congress 2012. Available at: http://www.uroweb.org/events/abstracts-online/?id=108&no- cache=1&AID=37373. Accessed April 2013
12. Lehrer RI, Lichtenstein AK, Ganz T,. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 1993; 11: 105-128
13. Rivas-Santiago B, Schwander SK, Sarabia C, et al. Human {beta}-defensin 2 is expressed and associated with Mycobacterium tuberculosis during infection of human alveolar epithelial cells. Infect Immun 2005; 73: 4505-4511
14. Chen F, Zhang G, Iwamoto Y, See WA,. BCG directly induces cell cycle arrest in human transitional carcinoma cell lines as a consequence of integrin cross-linking. BMC Urol 2005; 5: 8-17
15. Garden RJ, Liu BC, Redwood SM, Weiss RE, Droller MJ,. Bacillus Calmette-Guerin abrogates in vitro invasion and motility of human bladder tumor cells via fibronectin interaction. J Urol 1992; 148: 900-905
16. Pook SH, Esuvaranathan K, Mahendran R,. N-acetylcysteine augments the cellular redox changes and cytotoxic activity of internalized mycobacterium bovis in human bladder cancer cells. J Urol 2002; 168: 780-785
17. Morales A, Nickel JC, Wilson JW,. Dose-response of bacillus Calmette-Guerin in the treatment of superficial bladder cancer. J Urol 1992; 147: 1256-1258
18. Pagano F, Bassi P, Milani C, Meneghini A, Maruzzi D, Garbeglio A,. A low dose bacillus Calmette-Guerin regimen in superficial bladder cancer therapy: is it effective? J Urol 1991; 146: 32-35
19. Ojea A, Nogueira JL, Solsona E, et al. A multicentre, randomised prospective trial comparing three intravesical adjuvant therapies for intermediate-risk superficial bladder cancer: low-dose bacillus Calmette-Guerin (27 mg) versus very low-dose bacillus Calmette-Guerin (13.5 mg) versus mitomycin C. Eur Urol 2007; 52: 1398-1406
20. Alexandroff AB, Nicholson S, Patel PM, Jackson AM,. Recent advances in bacillus Calmette-Guerin immunotherapy in bladder cancer. Immunotherapy 2010; 2: 551-560
21. Miyazaki J, Kawai K, Oikawa T, et al. Uroepithelial cells can directly respond to Mycobacterium bovis bacillus Calmette-Guerin through Toll-like receptor signalling. BJU Int 2006; 97: 860-864
22. Ayari C, Bergeron A, LaRue H, Menard C, Fradet Y,. Toll-like receptors in normal and malignant human bladders. J Urol 2011; 185: 1915-1921
23. Scharf S, Hippenstiel S, Flieger A, Suttorp N, N'Guessan PD,. Induction of human beta-defensin-2 in pulmonary epithelial cells by Legionella pneumophila: involvement of TLR2 and TLR5, p38 MAPK, JNK, NF-kappaB, and AP-1. Am J Physiol Lung Cell Mol Physiol 2010; 298: L687-695
24. Siatelis A, Houhoula DP, Papaparaskevas J, Delakas D, Tsakris A,. Detection of bacillus Galmette-Guerin (Mycobacterium bovis BCG) DNA in urine and blood specimens after intravesical immunotherapy for bladder carcinoma. J Clin Microbiol 2011; 49: 1206-1208
25. Durek C, Richter E, Basteck A, et al. The fate of bacillus Calmette-Guerin after intravesical instillation. J Urol 2001; 165: 1765-1768